VIATRIS INC. Weighted Average Basic Shares Outstanding, Pro Forma
VIATRIS INC. (VTRS) reported Weighted Average Basic Shares Outstanding, Pro Forma of 1.17 billion shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageBasicSharesOutstandingProForma · last filed 2026-02-26
- VIATRIS INC. weighted average basic shares outstanding, pro forma for the quarter ending 2023-09-30 was 1.20B shares, a 1.07% decline year-over-year.
- VIATRIS INC. weighted average basic shares outstanding, pro forma for the quarter ending 2023-06-30 was 1.20B shares, a 1.10% decline year-over-year.
- VIATRIS INC. weighted average basic shares outstanding, pro forma for the quarter ending 2022-09-30 was 1.21B shares.
- VIATRIS INC. weighted average basic shares outstanding, pro forma for the quarter ending 2022-06-30 was 1.21B shares.
- VIATRIS INC. weighted average basic shares outstanding, pro forma for fiscal 2025 was 1.17B shares, a 1.89% decline from fiscal 2024.
- VIATRIS INC. weighted average basic shares outstanding, pro forma for fiscal 2024 was 1.19B shares, a 0.58% decline from fiscal 2023.
- VIATRIS INC. weighted average basic shares outstanding, pro forma for fiscal 2023 was 1.20B shares, a 0.97% decline from fiscal 2022.
- VIATRIS INC. weighted average basic shares outstanding, pro forma for fiscal 2022 was 1.21B shares.
| Period end | Weighted Average Basic Shares Outstanding, Pro Forma 3 month | Weighted Average Basic Shares Outstanding, Pro Forma 6 month | Weighted Average Basic Shares Outstanding, Pro Forma 9 month | Weighted Average Basic Shares Outstanding, Pro Forma 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.17B shares 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 1.19B shares 10-K · filed 2026-02-26 | |||
| 2023-12-31 | 1.20B shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 1.20B shares 10-Q · filed 2023-11-08 | 1.20B shares 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | 1.20B shares 10-Q · filed 2023-08-07 | 1.20B shares 10-Q · filed 2023-08-07 | ||
| 2022-12-31 | 1.21B shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 1.21B shares 10-Q · filed 2023-11-08 | 1.21B shares 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | 1.21B shares 10-Q · filed 2023-08-07 | 1.21B shares 10-Q · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |